表观基因组
表观遗传学
线粒体
癌症研究
细胞凋亡
细胞生物学
生物
癌细胞
化学
铼
DNA甲基化
癌症
生物化学
遗传学
基因表达
基因
无机化学
作者
Zhengyin Pan,Cai‐Ping Tan,Lu‐Si Rao,Hang Zhang,Yue Zheng,Hao Liang,Liang‐Nian Ji,Zong‐Wan Mao
标识
DOI:10.1002/anie.202008624
摘要
The development and malignancy of cancer cells are closely related to the changes of the epigenome. In this work, a mitochondria-targeted rhenium(I) complex (DFX-Re3), integrating the clinical iron chelating agent deferasirox (DFX), has been designed. By relocating iron to the mitochondria and changing the key metabolic species related to epigenetic modifications, DFX-Re3 can elevate the methylation levels of histone, DNA, and RNA. As a consequence, DFX-Re3 affects the events related to apoptosis, RNA polymerases, and T-cell receptor signaling pathways. Finally, it is shown that DFX-Re3 induces immunogenic apoptotic cell death and exhibits potent antitumor activity in vivo. This study provides a new approach for the design of novel epigenetic drugs that can recode the cancer epigenome by intervening in mitochondrial metabolism and iron homeostasis.
科研通智能强力驱动
Strongly Powered by AbleSci AI